[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267-225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Dr. Claudio  Dansky Ullmann M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.0, "open": 0.97, "dayLow": 0.9201, "dayHigh": 0.9964, "regularMarketPreviousClose": 1.0, "regularMarketOpen": 0.97, "regularMarketDayLow": 0.9201, "regularMarketDayHigh": 0.9964, "payoutRatio": 0.0, "beta": 2.179, "forwardPE": -3.2413795, "volume": 55912, "regularMarketVolume": 55912, "averageVolume": 164090, "averageVolume10days": 133100, "averageDailyVolume10Day": 133100, "bid": 0.6984, "ask": 1.21, "bidSize": 2, "askSize": 2, "marketCap": 89704200, "fiftyTwoWeekLow": 0.55, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 0.78402, "twoHundredDayAverage": 1.539685, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -9888502, "profitMargins": 0.0, "floatShares": 40555266, "sharesOutstanding": 89704200, "sharesShort": 2345042, "sharesShortPriorMonth": 2374938, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.026099999, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.81181, "shortRatio": 9.88, "shortPercentOfFloat": 0.0317, "impliedSharesOutstanding": 95430000, "bookValue": 1.062, "priceToBook": 0.88512236, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -26725104, "trailingEps": -0.46, "forwardEps": -0.29, "enterpriseToEbitda": 0.331, "52WeekChange": -0.31386864, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 0.94, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.6, "targetMedianPrice": 5.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 94429824, "totalCashPerShare": 1.053, "ebitda": -29913020, "totalDebt": 219380, "quickRatio": 34.358, "currentRatio": 35.619, "debtToEquity": 0.23, "returnOnAssets": -0.32757, "returnOnEquity": -0.49889, "freeCashflow": -36026380, "operatingCashflow": -14556434, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Context Therapeutics Inc.", "longName": "Context Therapeutics Inc.", "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.0, "regularMarketPrice": 0.94, "corporateActions": [], "postMarketTime": 1745613234, "regularMarketTime": 1745611202, "marketState": "CLOSED", "earningsTimestamp": 1742500800, "earningsTimestampStart": 1742500800, "earningsTimestampEnd": 1742500800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.46, "epsForward": -0.29, "epsCurrentYear": -0.282, "priceEpsCurrentYear": -3.3333333, "fiftyDayAverageChange": 0.15597999, "fiftyDayAverageChangePercent": 0.198949, "twoHundredDayAverageChange": -0.599685, "twoHundredDayAverageChangePercent": -0.3894855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "postMarketChangePercent": 5.0, "postMarketPrice": 0.987, "postMarketChange": 0.047, "regularMarketChange": -0.060000002, "regularMarketDayRange": "0.9201 - 0.9964", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 164090, "fiftyTwoWeekLowChange": 0.39, "fiftyTwoWeekLowChangePercent": 0.7090909, "fiftyTwoWeekRange": "0.55 - 2.75", "fiftyTwoWeekHighChange": -1.81, "fiftyTwoWeekHighChangePercent": -0.6581818, "fiftyTwoWeekChangePercent": -31.386864, "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]